Cargando…

Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: an individual participant data meta-analysis

BACKGROUND: The World Health Organization (WHO) recommends that outpatient people living with HIV (PLHIV) undergo tuberculosis screening with the WHO four-symptom screen (W4SS) or C-reactive protein (CRP) (5 mg·L(−1) cut-off) followed by confirmatory testing if screen positive. We conducted an indiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhana, Ashar, Gupta, Rishi K., Hamada, Yohhei, Kengne, Andre P., Kerkhoff, Andrew D., Yoon, Christina, Cattamanchi, Adithya, Reeve, Byron W.P., Theron, Grant, Ndlangalavu, Gcobisa, Wood, Robin, Drain, Paul K., Calderwood, Claire J., Noursadeghi, Mahdad, Boyles, Tom, Meintjes, Graeme, Maartens, Gary, Barr, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245131/
https://www.ncbi.nlm.nih.gov/pubmed/37286216
http://dx.doi.org/10.1183/16000617.0021-2023
_version_ 1785054796848300032
author Dhana, Ashar
Gupta, Rishi K.
Hamada, Yohhei
Kengne, Andre P.
Kerkhoff, Andrew D.
Yoon, Christina
Cattamanchi, Adithya
Reeve, Byron W.P.
Theron, Grant
Ndlangalavu, Gcobisa
Wood, Robin
Drain, Paul K.
Calderwood, Claire J.
Noursadeghi, Mahdad
Boyles, Tom
Meintjes, Graeme
Maartens, Gary
Barr, David A.
author_facet Dhana, Ashar
Gupta, Rishi K.
Hamada, Yohhei
Kengne, Andre P.
Kerkhoff, Andrew D.
Yoon, Christina
Cattamanchi, Adithya
Reeve, Byron W.P.
Theron, Grant
Ndlangalavu, Gcobisa
Wood, Robin
Drain, Paul K.
Calderwood, Claire J.
Noursadeghi, Mahdad
Boyles, Tom
Meintjes, Graeme
Maartens, Gary
Barr, David A.
author_sort Dhana, Ashar
collection PubMed
description BACKGROUND: The World Health Organization (WHO) recommends that outpatient people living with HIV (PLHIV) undergo tuberculosis screening with the WHO four-symptom screen (W4SS) or C-reactive protein (CRP) (5 mg·L(−1) cut-off) followed by confirmatory testing if screen positive. We conducted an individual participant data meta-analysis to determine the performance of WHO-recommended screening tools and two newly developed clinical prediction models (CPMs). METHODS: Following a systematic review, we identified studies that recruited adult outpatient PLHIV irrespective of tuberculosis signs and symptoms or with a positive W4SS, evaluated CRP and collected sputum for culture. We used logistic regression to develop an extended CPM (which included CRP and other predictors) and a CRP-only CPM. We used internal–external cross-validation to evaluate performance. RESULTS: We pooled data from eight cohorts (n=4315 participants). The extended CPM had excellent discrimination (C-statistic 0.81); the CRP-only CPM had similar discrimination. The C-statistics for WHO-recommended tools were lower. Both CPMs had equivalent or higher net benefit compared with the WHO-recommended tools. Compared with both CPMs, CRP (5 mg·L(−1) cut-off) had equivalent net benefit across a clinically useful range of threshold probabilities, while the W4SS had a lower net benefit. The W4SS would capture 91% of tuberculosis cases and require confirmatory testing for 78% of participants. CRP (5 mg·L(−1) cut-off), the extended CPM (4.2% threshold) and the CRP-only CPM (3.6% threshold) would capture similar percentages of cases but reduce confirmatory tests required by 24, 27 and 36%, respectively. CONCLUSIONS: CRP sets the standard for tuberculosis screening among outpatient PLHIV. The choice between using CRP at 5 mg·L(−1) cut-off or in a CPM depends on available resources.
format Online
Article
Text
id pubmed-10245131
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-102451312023-06-08 Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: an individual participant data meta-analysis Dhana, Ashar Gupta, Rishi K. Hamada, Yohhei Kengne, Andre P. Kerkhoff, Andrew D. Yoon, Christina Cattamanchi, Adithya Reeve, Byron W.P. Theron, Grant Ndlangalavu, Gcobisa Wood, Robin Drain, Paul K. Calderwood, Claire J. Noursadeghi, Mahdad Boyles, Tom Meintjes, Graeme Maartens, Gary Barr, David A. Eur Respir Rev Reviews BACKGROUND: The World Health Organization (WHO) recommends that outpatient people living with HIV (PLHIV) undergo tuberculosis screening with the WHO four-symptom screen (W4SS) or C-reactive protein (CRP) (5 mg·L(−1) cut-off) followed by confirmatory testing if screen positive. We conducted an individual participant data meta-analysis to determine the performance of WHO-recommended screening tools and two newly developed clinical prediction models (CPMs). METHODS: Following a systematic review, we identified studies that recruited adult outpatient PLHIV irrespective of tuberculosis signs and symptoms or with a positive W4SS, evaluated CRP and collected sputum for culture. We used logistic regression to develop an extended CPM (which included CRP and other predictors) and a CRP-only CPM. We used internal–external cross-validation to evaluate performance. RESULTS: We pooled data from eight cohorts (n=4315 participants). The extended CPM had excellent discrimination (C-statistic 0.81); the CRP-only CPM had similar discrimination. The C-statistics for WHO-recommended tools were lower. Both CPMs had equivalent or higher net benefit compared with the WHO-recommended tools. Compared with both CPMs, CRP (5 mg·L(−1) cut-off) had equivalent net benefit across a clinically useful range of threshold probabilities, while the W4SS had a lower net benefit. The W4SS would capture 91% of tuberculosis cases and require confirmatory testing for 78% of participants. CRP (5 mg·L(−1) cut-off), the extended CPM (4.2% threshold) and the CRP-only CPM (3.6% threshold) would capture similar percentages of cases but reduce confirmatory tests required by 24, 27 and 36%, respectively. CONCLUSIONS: CRP sets the standard for tuberculosis screening among outpatient PLHIV. The choice between using CRP at 5 mg·L(−1) cut-off or in a CPM depends on available resources. European Respiratory Society 2023-06-07 /pmc/articles/PMC10245131/ /pubmed/37286216 http://dx.doi.org/10.1183/16000617.0021-2023 Text en Copyright ©The authors 2023 https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org)
spellingShingle Reviews
Dhana, Ashar
Gupta, Rishi K.
Hamada, Yohhei
Kengne, Andre P.
Kerkhoff, Andrew D.
Yoon, Christina
Cattamanchi, Adithya
Reeve, Byron W.P.
Theron, Grant
Ndlangalavu, Gcobisa
Wood, Robin
Drain, Paul K.
Calderwood, Claire J.
Noursadeghi, Mahdad
Boyles, Tom
Meintjes, Graeme
Maartens, Gary
Barr, David A.
Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: an individual participant data meta-analysis
title Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: an individual participant data meta-analysis
title_full Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: an individual participant data meta-analysis
title_fullStr Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: an individual participant data meta-analysis
title_full_unstemmed Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: an individual participant data meta-analysis
title_short Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: an individual participant data meta-analysis
title_sort clinical utility of who-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with hiv: an individual participant data meta-analysis
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245131/
https://www.ncbi.nlm.nih.gov/pubmed/37286216
http://dx.doi.org/10.1183/16000617.0021-2023
work_keys_str_mv AT dhanaashar clinicalutilityofwhorecommendedscreeningtoolsanddevelopmentandvalidationofnovelclinicalpredictionmodelsforpulmonarytuberculosisscreeningamongoutpatientslivingwithhivanindividualparticipantdatametaanalysis
AT guptarishik clinicalutilityofwhorecommendedscreeningtoolsanddevelopmentandvalidationofnovelclinicalpredictionmodelsforpulmonarytuberculosisscreeningamongoutpatientslivingwithhivanindividualparticipantdatametaanalysis
AT hamadayohhei clinicalutilityofwhorecommendedscreeningtoolsanddevelopmentandvalidationofnovelclinicalpredictionmodelsforpulmonarytuberculosisscreeningamongoutpatientslivingwithhivanindividualparticipantdatametaanalysis
AT kengneandrep clinicalutilityofwhorecommendedscreeningtoolsanddevelopmentandvalidationofnovelclinicalpredictionmodelsforpulmonarytuberculosisscreeningamongoutpatientslivingwithhivanindividualparticipantdatametaanalysis
AT kerkhoffandrewd clinicalutilityofwhorecommendedscreeningtoolsanddevelopmentandvalidationofnovelclinicalpredictionmodelsforpulmonarytuberculosisscreeningamongoutpatientslivingwithhivanindividualparticipantdatametaanalysis
AT yoonchristina clinicalutilityofwhorecommendedscreeningtoolsanddevelopmentandvalidationofnovelclinicalpredictionmodelsforpulmonarytuberculosisscreeningamongoutpatientslivingwithhivanindividualparticipantdatametaanalysis
AT cattamanchiadithya clinicalutilityofwhorecommendedscreeningtoolsanddevelopmentandvalidationofnovelclinicalpredictionmodelsforpulmonarytuberculosisscreeningamongoutpatientslivingwithhivanindividualparticipantdatametaanalysis
AT reevebyronwp clinicalutilityofwhorecommendedscreeningtoolsanddevelopmentandvalidationofnovelclinicalpredictionmodelsforpulmonarytuberculosisscreeningamongoutpatientslivingwithhivanindividualparticipantdatametaanalysis
AT therongrant clinicalutilityofwhorecommendedscreeningtoolsanddevelopmentandvalidationofnovelclinicalpredictionmodelsforpulmonarytuberculosisscreeningamongoutpatientslivingwithhivanindividualparticipantdatametaanalysis
AT ndlangalavugcobisa clinicalutilityofwhorecommendedscreeningtoolsanddevelopmentandvalidationofnovelclinicalpredictionmodelsforpulmonarytuberculosisscreeningamongoutpatientslivingwithhivanindividualparticipantdatametaanalysis
AT woodrobin clinicalutilityofwhorecommendedscreeningtoolsanddevelopmentandvalidationofnovelclinicalpredictionmodelsforpulmonarytuberculosisscreeningamongoutpatientslivingwithhivanindividualparticipantdatametaanalysis
AT drainpaulk clinicalutilityofwhorecommendedscreeningtoolsanddevelopmentandvalidationofnovelclinicalpredictionmodelsforpulmonarytuberculosisscreeningamongoutpatientslivingwithhivanindividualparticipantdatametaanalysis
AT calderwoodclairej clinicalutilityofwhorecommendedscreeningtoolsanddevelopmentandvalidationofnovelclinicalpredictionmodelsforpulmonarytuberculosisscreeningamongoutpatientslivingwithhivanindividualparticipantdatametaanalysis
AT noursadeghimahdad clinicalutilityofwhorecommendedscreeningtoolsanddevelopmentandvalidationofnovelclinicalpredictionmodelsforpulmonarytuberculosisscreeningamongoutpatientslivingwithhivanindividualparticipantdatametaanalysis
AT boylestom clinicalutilityofwhorecommendedscreeningtoolsanddevelopmentandvalidationofnovelclinicalpredictionmodelsforpulmonarytuberculosisscreeningamongoutpatientslivingwithhivanindividualparticipantdatametaanalysis
AT meintjesgraeme clinicalutilityofwhorecommendedscreeningtoolsanddevelopmentandvalidationofnovelclinicalpredictionmodelsforpulmonarytuberculosisscreeningamongoutpatientslivingwithhivanindividualparticipantdatametaanalysis
AT maartensgary clinicalutilityofwhorecommendedscreeningtoolsanddevelopmentandvalidationofnovelclinicalpredictionmodelsforpulmonarytuberculosisscreeningamongoutpatientslivingwithhivanindividualparticipantdatametaanalysis
AT barrdavida clinicalutilityofwhorecommendedscreeningtoolsanddevelopmentandvalidationofnovelclinicalpredictionmodelsforpulmonarytuberculosisscreeningamongoutpatientslivingwithhivanindividualparticipantdatametaanalysis